Impact of multimodal therapy in locally recurrent rectal cancer. Issue 6 (2nd March 2016)

• Record Type: Journal Article
• Authors: You, Y. N.; Skibber, J. M.; Hu, C.‐Y.; Crane, C. H.; Das, P.; Kopetz, E. S.; Eng, C.; Feig, B. W.; Rodriguez‐Bigas, M. A.; Chang, G. J.
• Is Part Of: British journal of surgery. Volume 103:Issue 6(2016)
• Page Start: 753
• Page End: 762
• Publication Date: 2016-03-02
• Subjects: Surgery -- Periodicals; 617.005
• DOI: 10.1002/bjs.10079
• Languages: English
• ISSNs: 0007-1323

Abstract

Abstract: Background: The practice of salvaging recurrent rectal cancer has evolved. The aim of this study was to define the evolving salvage potential over time among patients with locally recurrent disease, and to identify durable determinants of long‐term success. Methods: The study included consecutive patients with recurrent rectal cancer undergoing multimodal salvage with curative intent between 1988 and 2012. Predictors of long‐term survival were defined by Cox regression analysis and compared over time. Re‐recurrence and subsequent treatments were evaluated. Results: After multidisciplinary evaluation of 229 patients, salvage therapy with curative intent included preoperative chemotherapy and/or radiotherapy (73·4 per cent; with 41·3 per cent undergoing repeat pelvic irradiation), surgical salvage resection with or without intraoperative irradiation (36·2 per cent), followed by postoperative adjuvant chemotherapy (38·0 per cent). Multivisceral resection was undertaken in 47·2 per cent and bone resection in 29·7 per cent. The R0 resection rate was 80·3 per cent. After a median follow‐up of 56·5 months, the 5‐year overall survival rate was 50 per cent in 2005–2012, markedly increased from 32 per cent in 1988–1996 ( P = 0·044). Long‐term success was associated with R0 resection ( P = 0·017) and lack of secondary failure ( P = 0·003). Some 125 patients (54·6 per cent) developed further recurrence at a median of 19·4 months after salvage surgery. Repeat operative rescue was feasible in 21 of 48 patients with local re‐recurrence alone and in 17 of 77 with distant re‐recurrence, with a median survival of 19·8 months after further recurrence. Conclusion: The long‐term salvage potential for recurrent rectal cancer improved significantly over time, with the introduction of an individualized treatment algorithm of multimodal treatments and surgical salvage. Durable predictors of long‐term success were R0 resection at salvage operation, avoidance of secondary failure, and feasibility of repeat rescue after re‐recurrence. Abstract : Options for treatment